IDH1 and astrocytic tumor: In contrast with IDH1/2 mutations and decreased ATRX expression being widely considered as key aberrations in the early stage of astrocytic tumors [7, 35], increasing Ki-67 expression may be the final event in the progression of these tumors [9, 10, 33].